DAVITA INC. Revenue
DAVITA INC. (DVA) reported Revenue of $3.55 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-04
- DAVITA INC. revenues for the quarter ending 2026-06-30 was $3.55B, a 5.17% increase year-over-year.
- DAVITA INC. revenues for the quarter ending 2026-03-31 was $3.42B, a 5.96% increase year-over-year.
- DAVITA INC. revenues for the quarter ending 2025-12-31 was $3.62B, a 9.87% increase year-over-year.
- DAVITA INC. revenues for the quarter ending 2025-09-30 was $3.42B, a 4.80% increase year-over-year.
- DAVITA INC. revenues for fiscal 2025 was $13.64B, a 6.46% increase from fiscal 2024.
- DAVITA INC. revenues for fiscal 2024 was $12.82B, a 5.56% increase from fiscal 2023.
- DAVITA INC. revenues for fiscal 2023 was $12.14B, a 4.57% increase from fiscal 2022.
- DAVITA INC. revenues for fiscal 2022 was $11.61B, a 0.08% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.55B 10-Q · filed 2026-08-04 | $6.97B 10-Q · filed 2026-08-04 | $10.59B derived: sum of 3 quarters · filed 2026-08-04 | $14.01B derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.42B 10-Q · filed 2026-05-05 | $7.04B derived: sum of 2 quarters · filed 2026-05-05 | $10.46B derived: sum of 3 quarters · filed 2026-05-05 | $13.84B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.62B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $7.04B derived: sum of 2 quarters · filed 2026-02-11 | $10.42B derived: sum of 3 quarters · filed 2026-08-04 | $13.64B 10-K · filed 2026-02-11 |
| 2025-09-30 | $3.42B 10-Q · filed 2025-10-29 | $6.80B derived: sum of 2 quarters · filed 2026-08-04 | $10.02B 10-Q · filed 2025-10-29 | $13.32B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $3.38B 10-Q · filed 2026-08-04 | $6.60B 10-Q · filed 2026-08-04 | $9.90B derived: sum of 3 quarters · filed 2026-08-04 | $13.16B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $3.22B 10-Q · filed 2026-05-05 | $6.52B derived: sum of 2 quarters · filed 2026-05-05 | $9.78B derived: sum of 3 quarters · filed 2026-05-05 | $12.97B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.29B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $6.56B derived: sum of 2 quarters · filed 2026-02-11 | $9.74B derived: sum of 3 quarters · filed 2026-02-11 | $12.82B 10-K · filed 2026-02-11 |
| 2024-09-30 | $3.26B 10-Q · filed 2025-10-29 | $6.45B derived: sum of 2 quarters · filed 2025-10-29 | $9.52B 10-Q · filed 2025-10-29 | $12.67B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $3.19B 10-Q · filed 2025-08-05 | $6.26B 10-Q · filed 2025-08-05 | $9.40B derived: sum of 3 quarters · filed 2026-02-11 | $12.52B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $3.07B 10-Q · filed 2025-05-12 | $6.22B derived: sum of 2 quarters · filed 2026-02-11 | $9.34B derived: sum of 3 quarters · filed 2026-02-11 | $12.34B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $3.15B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $6.27B derived: sum of 2 quarters · filed 2026-02-11 | $9.27B derived: sum of 3 quarters · filed 2026-02-11 | $12.14B 10-K · filed 2026-02-11 |
| 2023-09-30 | $3.12B 10-Q · filed 2024-10-29 | $6.12B derived: sum of 2 quarters · filed 2024-10-29 | $8.99B 10-Q · filed 2024-10-29 | $11.91B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $3.00B 10-Q · filed 2024-08-06 | $5.87B 10-Q · filed 2024-08-06 | $8.79B derived: sum of 3 quarters · filed 2025-02-13 | $11.74B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $2.87B 10-Q · filed 2024-05-02 | $5.79B derived: sum of 2 quarters · filed 2025-02-13 | $8.74B derived: sum of 3 quarters · filed 2025-02-13 | $11.67B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $2.92B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $5.87B derived: sum of 2 quarters · filed 2025-02-13 | $8.79B derived: sum of 3 quarters · filed 2025-02-13 | $11.61B 10-K · filed 2025-02-13 |
| 2022-09-30 | $2.95B 10-Q · filed 2023-11-07 | $5.88B derived: sum of 2 quarters · filed 2023-11-07 | $8.69B 10-Q · filed 2023-11-07 | $11.64B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $2.93B 10-Q · filed 2023-08-03 | $5.74B 10-Q · filed 2023-08-03 | $8.69B derived: sum of 3 quarters · filed 2024-02-14 | $11.63B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $2.82B 10-Q · filed 2023-05-08 | $5.76B derived: sum of 2 quarters · filed 2024-02-14 | $8.70B derived: sum of 3 quarters · filed 2024-02-14 | $11.62B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $2.94B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $5.88B derived: sum of 2 quarters · filed 2024-02-14 | $8.80B derived: sum of 3 quarters · filed 2024-02-14 | $11.62B 10-K · filed 2024-02-14 |
| 2021-09-30 | $2.94B 10-Q · filed 2022-10-31 | $5.85B derived: sum of 2 quarters · filed 2022-10-31 | $8.67B 10-Q · filed 2022-10-31 | $11.58B derived: sum of 4 quarters · filed 2022-10-31 |
| 2021-06-30 | $2.92B 10-Q · filed 2022-08-01 | $5.74B 10-Q · filed 2022-08-01 | $8.64B derived: sum of 3 quarters · filed 2022-08-01 | $11.57B derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $2.82B 10-Q · filed 2022-05-05 | $5.73B derived: sum of 2 quarters · filed 2022-05-05 | $8.65B derived: sum of 3 quarters · filed 2022-05-05 | $11.53B derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $2.91B 10-K · filed 2021-02-12 | $5.83B derived: sum of 2 quarters · filed 2021-10-28 | $8.71B derived: sum of 3 quarters · filed 2021-10-28 | $11.55B 10-K · filed 2023-02-22 |
| 2020-09-30 | $2.92B 10-Q · filed 2021-10-28 | $5.80B derived: sum of 2 quarters · filed 2021-10-28 | $8.65B 10-Q · filed 2021-10-28 | $11.54B derived: sum of 4 quarters · filed 2021-10-28 |
| 2020-06-30 | $2.88B 10-Q · filed 2021-08-03 | $5.72B 10-Q · filed 2021-08-03 | $8.62B derived: sum of 3 quarters · filed 2021-08-03 | $11.52B derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $2.84B 10-Q · filed 2021-04-29 | $5.74B derived: sum of 2 quarters · filed 2021-04-29 | $8.64B derived: sum of 3 quarters · filed 2021-04-29 | $11.49B derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $2.90B 10-K · filed 2021-02-12 | $5.80B derived: sum of 2 quarters · filed 2021-02-12 | $8.65B derived: sum of 3 quarters · filed 2021-02-12 | $11.39B 10-K · filed 2022-02-11 |
| 2019-09-30 | $2.90B 10-K · filed 2021-02-12 | $5.75B derived: sum of 2 quarters · filed 2021-02-12 | $8.49B 10-Q · filed 2020-10-29 | $11.31B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $2.84B 10-K · filed 2021-02-12 | $5.59B 10-Q · filed 2020-07-30 | $8.41B derived: sum of 3 quarters · filed 2021-02-12 | $11.25B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $2.74B 10-K · filed 2021-02-12 | $5.56B derived: sum of 2 quarters · filed 2021-02-12 | $8.41B derived: sum of 3 quarters · filed 2021-02-12 | $11.30B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $2.82B 10-K · filed 2020-02-21 | $5.67B derived: sum of 2 quarters · filed 2020-02-21 | $8.56B derived: sum of 3 quarters · filed 2020-02-21 | $11.40B 10-K · filed 2021-02-12 |
| 2018-09-30 | $2.85B 10-K · filed 2020-02-21 | $5.73B derived: sum of 2 quarters · filed 2020-02-21 | $8.58B 10-Q · filed 2019-11-07 | $11.36B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $2.89B 10-K · filed 2020-02-21 | $5.74B 10-Q · filed 2019-08-02 | $8.52B derived: sum of 3 quarters · filed 2020-02-21 | $11.28B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $2.85B 10-K · filed 2020-02-21 | $5.63B derived: sum of 2 quarters · filed 2020-02-21 | $8.40B derived: sum of 3 quarters · filed 2020-02-21 | $11.09B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $2.78B 10-K · filed 2019-02-22 | $5.55B derived: sum of 2 quarters · filed 2019-02-22 | $8.25B derived: sum of 3 quarters · filed 2019-02-22 | $10.88B 10-K · filed 2020-02-21 |
| 2017-09-30 | $2.77B 10-K · filed 2019-02-22 | $5.46B derived: sum of 2 quarters · filed 2019-02-22 | $8.10B 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $2.70B 10-K · filed 2019-02-22 | $5.33B 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $2.63B 10-K · filed 2019-02-22 | |||
| 2016-12-31 | $10.71B 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |